Universe Pharmaceuticals INC (UPC) KPIs and segments
Close on Nov 13, 2026Market cap $850.64KP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Universe Pharmaceuticals's business
Universe Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
Universe Pharmaceuticals's fiscal year ends September 30 — FY2025 = CY2025 (calendar year).
| Add to chart | Metric | FY2025 CY2025 | FY2024 CY2024 | FY2023 CY2023 |
|---|---|---|---|---|
Revenue from sales of self-manufactured TCMD products($M) | 13,261 | 14,026 | 18,573 | |
Revenue from sales of third-party products($M) | 4,598 | 8,998 | 13,736 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-01-29.
See a number that looks wrong?